References
- Walley AY, Xuan Z, Hackman H, et al. Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: interrupted time series analysis. BMJ. 2013;346:1–12.
- Hardman JG, Limbird LE, eds. Goodman and Gilman's the Pharmacologic Basis of Therapeutics. 11th ed. New York, NY: McGraw-Hill; 2006;576–578.
- Mueller S, Walley AY, Calcaterra SL, Glanz JM, Binswanger IA. A review of opioid overdose prevention and naloxone prescribing: implications for translating community programming into clinical practice. Subst Abus. 2015;36:240–253.
- Wheeler E, Jones TS, Gilbert MK, Davidson PJ. Opioid overdose prevention programs providing naloxone to laypersons—United States, 2014. MMWR Morb Mortal Wkly Rep. 2015;64:631–635.
- Substance Abuse and Mental Health Services Administration. SAMHSA Opioid Overdose Prevention Toolkit. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2014. HHS Publication No. (SMA)14-4742.
- FDA approves new hand-held auto-injector to reverse opioid overdose. US Food and Drug Administration Web site. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm391465.htm. Published April 3, 2014. Accessed November 15, 2015.
- Fact Sheet: Preventing, Treating and Surviving Overdose. White House Office of National Drug Control Web site. https://www.whitehouse.gov/sites/default/files/ondcp/prevention/overdose_fact_sheet.pdf. Published August 28, 2013. Accessed November 15, 2015.
- Substance Abuse and Mental Health Services Administration. Federal Guidelines for Opioid Treatment Programs. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2015. HHS Publication No. (SMA) PEP15-FEDGUIDEOTP: 24.
- Knudsen H, Roman PM. The transition to medication adoption in publicly funded substance use disorder treatment programs: organizational structure, culture, and resources. J Stud Alcohol Drugs. 2014;75:476–485.
- Williams AV, Marsden J, Strang J. Training family members to manage heroin overdose and administer naloxone: randomized trial of effects on knowledge and attitudes. Addiction. 2014;109:250–259.
- Wheeler E, Burk K, McQuie H, Stancliff S. Guide to developing and managing overdose prevention and take-home naloxone projects. The Harm Reduction Coalition. Fall 2012. http://harmreduction.org/issues/overdose-prevention/tools-best-practices/manuals-best-practice/od-manual/.Accessed November 15, 2015.
- Doe-Simkins M, Walley AY, Epstein A, Moyer P. Saved by the nose: bystander-administered intranasal naloxone hydrochloride for opioid overdose. Am J Public Health. 2009;99:788–791.
- Leavit SB. Intranasal naloxone for the at-home opioid rescue. Pract Pain Manag. 2010;10:42–46.
- Drug overdose prevention and harm reduction. The Network for Public Law Web site. https://www.networkforphl.org/topics__resources/topics__resources/drug_overdose_prevention_and_harm_reduction/. Accessed November 15, 2015.
- Naloxone overdose prevention laws. Law Atlas, The Policy Surveillance Portal. http://lawatlas.org/query?dataset=laws-regulating-administration-of-naloxone. Published July 2015. Accessed November 15, 2015.
- Stang J, Manning V, Mayet S, et al. Overdose training and take-home naloxone for opiate users: prospective cohort study of impact on knowledge and attitudes and subsequent management of overdoses. Addiction. 2008;103:1648–1657.
- Wagner K, Valente T, Casanova M, et al. Evaluation of an overdose prevention and response training programme for injection drug users in the Skid Row area of Los Angeles, CA. Int J Drug Policy. 2010;21:186–193.
- Williams A, Strang J, Marsden J. Development of Opioid Overdose Knowledge (OOKS) and Attitudes (OOAS) Scales for take-home naloxone training evaluation. Drug Alcohol Depend. 2013;132:383–386.
- Bazazi A, Zaller M, Fu J, Rich J. Preventing opiate overdose deaths: examining objections to take-home naloxone. J Health Care Poor Underserved. 2010;21:1108–1113.